Company performance
Add to research
Current Price
as of Apr 21, 2025$9.58
P/E Ratio
N/A
Market Cap
$1.23B
Description
Add to research
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.
Metrics
Add to research
Overview
- HQFort Myers, FL
- SectorHealth Services
- IndustryMedical/Nursing Services
- TickerNEO
- Price$9.58+0.31%
Trading Information
- Market cap$1.23B
- Float98.80%
- Average Daily Volume (1m)1,801,931
- Average Daily Volume (3m)1,425,712
- EPS-$0.62
Company
- Revenue$660.57M
- Rev growth (1yr)11.65%
- Net income-$78.73M
- Gross margin38.85%
- EBITDA margin0.13%
- EBITDA$0.85M
- EV$2.31B
- EV/Revenue3.49
- P/EN/A
- P/S1.84
- P/B1.36
- Debt/Equity67.08
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account